Could you add weight to your portfolio by taking a slice of Eli Lilly? Or should you opt for Novo Nordisk?Read More

You might also be interested in reading Grayscale Battling Outflows And Lower-Cost ETFs, Q1 Revenue Stays Flat At $156M.